重组抗肿瘤抗病毒蛋白的三维结构预测及其与受体的相互作用分析
Structure prediction for recombinant antitumor-antivirus protein and analysis of the interaction with its receptor
分类号:
出版年·卷·期(页码):2014,34 (12):0-0
DOI:
10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------
目的: 利用计算机模拟的方法分析重组抗肿瘤抗病毒蛋白(乐复能)的抗病毒及抗肿瘤活性优于普通干扰素(IFNα-2b)的机制.方法: 通过对乐复能、乐复能与干扰素受体形成复合物的结构预测,分析乐复能与其受体的相互作用.结果: 与IFNα-2b相比较,乐复能和受体IFNR1的相互作用力有了明显的提高,结合更加紧密.结论: 计算机模拟的方法可以有效地应用于尚无晶体信息的蛋白类药物及其与受体相互作用的结构预测.
-----英文摘要:---------------------------------------------------------------------------------------
Objective: To analyze the mechanism of the superior activities of recombinant antitumor-antivirus protein(novaferon)to those of IFNα-2b by using computer simulation. Methods: The structures of novaferon and the novaferon-receptor complex were predicted in order to study the mutual interaction of novaferon and its receptor. Results: The mutual interaction force of novaferon and IFNR1 was improved obviously compared with IFNα-2b, and the conjunction was tighter. Conclusion: The method by computer stimulation can be effectively applied to the structure prediction of protein drugs interacting with their receptors which had no clear crystal information.
-----参考文献:---------------------------------------------------------------------------------------
[1] WANG Jun-zhi(王军志).Development and Quality Control of Biopharmaceuticals(生物技术药物研究开发和质量控制)[M].2nd Ed(第2版).Beijing(北京):Science Press(科学出版社),2007:120
[2] Locher CP,Paidhungat M,Whalen RG, et al.DNA shuffling and screening strategies for improving vaccine efficacy [J].DNA Cell Biol,2005,24(4):256
[3] HAN Chuang(韩闯),YANG Sheng-chang(杨胜昌).High throughout screening assay and application(高通量筛选技术及其应用)[J].Biotechnol Bull(生物技术通报),2005,2(1):22
[4] PEI De-ning(裴德宁),RAO Chun-ming(饶春明),LI Yong-hong(李永红).Establishment of quality control methods and standards for recombinant antitumor-antivirus-protein novaferon(重组抗肿瘤抗病毒蛋白乐复能质控方法与质量标准的建立)[J].Chin J Cancer Biother(中国肿瘤生物治疗杂志),2009,16(4):364
[5] WANG Xia(王夏),LI Bei-ping(李北平),TAN Ming-feng(谭明锋),et al.Prediction of functional modules from protein-protein interaction network by bioinformatics method(生物信息学方法预测蛋白质相互作用网络中的功能模块)[J].Biotechnol Bull(生物技术通报),2009,20(3):430
[6] YUE Jun-jie(岳俊杰),WANG Li(汪莉),WANG Yue-lan(王月兰),et al.Three dimensional structure prediction of SARS coronavirus S protein(SARS病毒蛋白三维结构预测)[J].Biotechnol Bull(生物技术通报),2003,14(5):399
[7] YUE Jun-jie(岳俊杰),LIANG Long(梁龙),WANG Yue-lan(王月兰),et al.Three dimensional structure modeling and structure-funtion relationship study of first three domains of insuin receptor(胰岛素受体胞外区三维结构的模建及结构功能关系)[J].Biotechnol Bull(生物技术通报),2002,13(1):30
[8] Ming L,Xiao JC,Ping L,et al.Study on inhibitory and binding mode of the hydroxycoumarin compound NSC158393 to HIV-1 integrase by molecular modeling[J].Biopolyer,2009,91(9):700
[9] Ming L,Ji GS,Ren K,et al.Molecular dynamics simulations of the bacterial periplasmic heme binding proteins ShuT and PhuT[J].Biophys Chem,2008,138(1):42
[10] Ming L,Ting GS,Jian PH,et al.Study on the mechanism of the BtuF periplasmic-binding protein for vitamin B12 [J].Biophys Chem,2008,135(1):19
[11] WANG Jia-li(王家丽),LI Xiu-jun(李秀钧).Obesity and hepatic adipose infiltration(肥胖与脂肪肝)[J].Chin J Postgard Med(医师进修杂志),2004,27(15):9
[12] CHEN Jian-mei(陈坚梅),GU Wei-zheng(顾维正).Obesity and diabetes(肥胖与糖尿病)[J].Chin J Postgard Med(医师进修杂志),2004,27(15):11
[13] BI Hua(毕华),YUE Jun-jie(岳俊杰),YUAN Li-yong(袁立勇),et al.The design and bioactivity analysis of CNTF mutants(睫状神经营养因子突变体的设计及活性分析)[J].Prog Biochem Biophys(生物化学与生物物理进展),2007,34(4):408
[14] LI Qi-zhang(李奇璋),HUANG Lei(黄蕾),ZHOU Xuan-wei(周选围),et al.DNA-shuffling technology and its application in directed evolution of protein drugs(DNA改组技术及其在蛋白类药物定向进化中的应用)[J].Chin Remed Clin(中国药物与临床),2008,8(8):589
[15] Sammond DW,Eletr ZM,Purbeck C,et al.Computational design of second-site suppressor mutations at protein-protein interfaces[J].Proteins,2010,78(4):1055
[16] Potapov V,Cohen M,Schreiber G.Assessing computational methods for predicting protein stability upon mutation:good on average but not in the details[J].Protein Eng Des Sel,2009,22(9):553
欢迎阅读《药物分析杂志》!您是该文第 825位读者!